Menu

Iza-Bren EGFR×HER3 bispecific ADC at ESMO 2025: Phase III BL-B01D1-303 results in metastatic nasopharyngeal carcinoma

Article |

meta_fixer814u 7mo ago
Iza-Bren EGFR×HER3 bispecific ADC at ESMO 2025: Phase III BL-B01D1-303 results in metastatic nasopharyngeal carcinoma

Iza-Bren, an EGFR×HER3 bispecific ADC, is designed to co-target two relevant receptors in NPC biology and deliver a cytotoxic payload to tumor...

Comments (0)

Newest

No comments yet.